{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:23:21Z","timestamp":1760955801272,"version":"3.40.5"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ijrobp.2018.04.009","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T06:45:46Z","timestamp":1523429146000},"page":"957-963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Acute Epithelial Toxicity Is Prognostic for Improved Prostate Cancer Response to Radiation Therapy: A Retrospective, Multicenter, Cohort Study"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4324-1886","authenticated-orcid":false,"given":"Thomas","family":"Eade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3561-6580","authenticated-orcid":false,"given":"Ananya","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2632-579X","authenticated-orcid":false,"given":"Matthew","family":"Abramowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix M.","family":"Chinea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linxin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Louw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4193-9682","authenticated-orcid":false,"given":"George","family":"Hruby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7629-504X","authenticated-orcid":false,"given":"Andrew","family":"Kneebone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0839-3449","authenticated-orcid":false,"given":"Catharine","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2018.04.009_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/ejh.12400","article-title":"Severe radiotoxicity in an allogeneic transplant recipient with a heterozygous ATM mutation","volume":"95","author":"Ostendorf","year":"2015","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ijrobp.2018.04.009_bib2","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1200\/JCO.2011.40.1430","article-title":"Radiation therapy and adjuvant chemotherapy in a patient with a malignant glioneuronal tumor and underlying ataxia telangiectasia: A case report and review of the literature","volume":"31","author":"DeWire","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.04.009_bib3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.radonc.2016.06.017","article-title":"Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients","volume":"121","author":"Andreassen","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2018.04.009_bib4","doi-asserted-by":"crossref","first-page":"10312","DOI":"10.18632\/oncotarget.14400","article-title":"Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2018.04.009_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1748-717X-9-217","article-title":"Association between radiation pneumonitis and tumor response in patients with NSCLC treated with chemoradiation","volume":"9","author":"MacManus","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2018.04.009_bib6","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/j.1464-410X.2011.10668.x","article-title":"Image-guided dose-escalated intensity-modulated radiation therapy for prostate cancer: Treating to doses beyond 78 Gy","volume":"109","author":"Eade","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2018.04.009_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jclinepi.2016.06.005","article-title":"The reporting of studies using routinely collected health data was often insufficient","volume":"79","author":"Hemkens","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijrobp.2018.04.009_bib8","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ijrobp.2006.10.023","article-title":"Radiation dose and late failures in prostate cancer","volume":"67","author":"Morgan","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.04.009_bib9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.clon.2013.04.001","article-title":"RAPPER: The radiogenomics of radiation toxicity","volume":"25","author":"Burnet","year":"2013","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2018.04.009_bib10","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ijrobp.2011.07.019","article-title":"Inverse relationship between biochemical outcome and acute toxicity after image-guided radiotherapy for prostate cancer","volume":"83","author":"Vesprini","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.04.009_bib11","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1016\/S1470-2045(15)00007-8","article-title":"Radiation and checkpoint blockade immunotherapy: Radiosensitisation and potential mechanisms of synergy","volume":"16","author":"Sharabi","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2018.04.009_bib12","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1200\/JCO.2005.05.2530","article-title":"Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy","volume":"24","author":"Peeters","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.04.009_bib13","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ijrobp.2010.03.049","article-title":"70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial","volume":"80","author":"Beckendorf","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.04.009_bib14","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2007.11.054","article-title":"Observations on real-time prostate gland motion using electromagnetic tracking","volume":"71","author":"Langen","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.04.009_bib15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1470-2045(11)70063-8","article-title":"Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial","volume":"12","author":"Denham","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2018.04.009_bib16","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S1470-2045(10)70223-0","article-title":"External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study","volume":"11","author":"Bolla","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2018.04.009_bib17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ijrobp.2014.03.009","article-title":"Radiogenomics: Radiobiology enters the era of big data and team science","volume":"89","author":"Rosenstein","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.04.009_bib18","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.ijrobp.2009.12.017","article-title":"Establishment of a Radiogenomics Consortium","volume":"76","author":"West","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.04.009_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ijrobp.2016.05.027","article-title":"The Henri Mondor Procedure of Morbidity and Mortality Review Meetings: Prospective registration of clinical, dosimetric, and individual radiosensitivity data of patients with severe radiation toxicity","volume":"96","author":"Belkacemi","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.04.009_bib20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1470-2045(16)30648-9","article-title":"A genome-based model for adjusting radiotherapy dose (GARD): A retrospective, cohort-based study","volume":"18","author":"Scott","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2018.04.009_bib21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.clon.2014.09.008","article-title":"The REQUITE project: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in cancer survivors","volume":"26","author":"West","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618306606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618306606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T13:57:24Z","timestamp":1604152644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301618306606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0360301618306606"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.04.009","relation":{},"ISSN":["0360-3016"],"issn-type":[{"type":"print","value":"0360-3016"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Epithelial Toxicity Is Prognostic for Improved Prostate Cancer Response to Radiation Therapy: A Retrospective, Multicenter, Cohort Study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}